LYMPHANGIOMA

Clinical trials for LYMPHANGIOMA explained in plain language.

Never miss a new study

Get alerted when new LYMPHANGIOMA trials appear

Sign up with your email to follow new studies for LYMPHANGIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New hope for rare blood vessel disorders: targeted drugs enter trial

Disease control Recruiting now

This study tests two targeted drugs for people with abnormal blood vessels (vascular malformations). One drug, alpelisib, is for slow-flow types; the other, mirdametinib, is for fast-flow types. About 50 participants aged 2 and older will take the drug for 48 weeks to see if thei…

Matched conditions: LYMPHANGIOMA

Phase: PHASE2 • Sponsor: Murdoch Childrens Research Institute • Aim: Disease control

Last updated May 12, 2026 13:41 UTC

LYMPHANGIOMA

Get alerted when new LYMPHANGIOMA trials appear

New hope for rare blood vessel disorders: targeted drugs enter trial